Vital KSK Holdings, Inc.

Research Vital KSK Holdings, Inc. (3151.T) on Bullrun: market cap JPY 73.46B, P/E 10.6, dividend yield 4.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is JPY 73.46B; P/E is 10.6; dividend yield is 4.6%.

Peer valuation comparison

Latest P/E is 10.61x versus a Healthcare sector median of 21.69x (51.1% below).

Latest dividend yield is 4.62% versus a Healthcare sector median of 2.41% (91.7% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026JPY 610.50BJPY 7.36B-JPY 435.00M8.1%152.29JPY 22.95BJPY 6.78BJPY 117.22B
FY2025JPY 600.37BJPY 7.31B-JPY 12.36B8.2%149.02JPY 23.10BJPY 7.70BJPY 105.91B
FY2024JPY 587.48BJPY 5.84BJPY 18.47B8.2%115.03JPY 34.71BJPY 9.11BJPY 104.66B
FY2023JPY 581.33BJPY 4.83B-JPY 9.60B8.0%92.69JPY 19.03BJPY 10.25BJPY 98.99B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18JPY 73.46B10.64.5%70

Dividend history

Latest trailing dividend snapshot: annual dividend/share 70 JPY, yield 4.6%.

YearDividends/share
FY202671 JPY
FY202558 JPY
FY202444 JPY
FY202346 JPY

About Vital KSK Holdings, Inc.

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Vital KSK Holdings, Inc.'s market cap?

Vital KSK Holdings, Inc.'s market capitalization is JPY 73.46B.

What is Vital KSK Holdings, Inc.'s P/E ratio?

Vital KSK Holdings, Inc.'s price-to-earnings (P/E) ratio is 10.6.

Does Vital KSK Holdings, Inc. pay a dividend?

Vital KSK Holdings, Inc. has a dividend yield of 4.6%.

What does Vital KSK Holdings, Inc. do?

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals for scientific use.